Cali Health Dept warns about weight loss peptides

AI executive summary
The story at a glance, best enjoyed with a coffee ☕
The Secretaría de Salud de Cali has issued a warning about the use of peptides for weight loss, highlighting that these medications can cause adverse effects and must be supervised by professionals. Treatments with GLP hormones, such as semaglutide and tirzepatide, have gained popularity to combat obesity and overweight, working by decreasing appetite and stimulating insulin. Germán Escobar, secretary of Health of Cali, emphasized that these drugs are not for aesthetic use and require professional assessment to weigh the risk-benefit, in addition to having Invima sanitary registration.
🔔 Sign in to follow this story and get its updates.
In this story you will find
AI analysis
Why it matters
This warning directly affects people who use or consider using these medications without medical supervision, putting their health at risk due to possible uncontrolled adverse effects.
Other coverage of this story (2 sources)
Coverage radar
2 reports from 2 outlets, in publication order
Publication timeline
When each outlet published its report
- El Tiempo CaliCali Health Dept warns about dangerous weight loss peptides
- 90 MinutosCali Health Dept warns about weight loss peptides
New themes as coverage developed
Topics are AI-generated from headlines and summaries. They show what appeared in the coverage, not proof that earlier reports omitted or contradicted a fact.
- 90 Minutosalso mentionssalud
▸▾ Rate, add sources or report this story
Sign in to rate this story and add sources.
Community annexes
Coverage of this same story by other outlets, contributed by readers and checked automatically.
Ask about this coverage
Get an AI answer grounded in reports from different outlets, with links to the sources.